Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic
出版年份 2017 全文链接
标题
Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 24, Issue 9, Pages T83-T96
出版商
Bioscientifica
发表日期
2017-03-02
DOI
10.1530/erc-17-0003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A USP28–53BP1–p53–p21 signaling axis arrests growth after centrosome loss or prolonged mitosis
- (2016) Bramwell G. Lambrus et al. JOURNAL OF CELL BIOLOGY
- 53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration
- (2016) Franz Meitinger et al. JOURNAL OF CELL BIOLOGY
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival
- (2016) Yubao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prolonged mitotic arrest induces a caspase-dependent DNA damage response at telomeres that determines cell survival
- (2016) Karolina O. Hain et al. Scientific Reports
- Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers
- (2016) Ailsa Bennett et al. Open Biology
- 53BP1 and USP28 mediate p53-dependent cell cycle arrest in response to centrosome loss and prolonged mitosis
- (2016) Chii Shyang Fong et al. eLife
- MYC Is a Major Determinant of Mitotic Cell Fate
- (2015) Caroline Topham et al. CANCER CELL
- Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells
- (2015) Minji Choi et al. CANCER LETTERS
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
- (2015) Daniel Sanghoon Shin et al. CURRENT OPINION IN IMMUNOLOGY
- Aurora Kinase Inhibitors: Current Status and Outlook
- (2015) Vassilios Bavetsias et al. Frontiers in Oncology
- Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle
- (2014) Yanting Zhu et al. CELL CYCLE
- Immuno-oncology Combinations: A Review of Clinical Experience and Future Prospects
- (2014) S. J. Antonia et al. CLINICAL CANCER RESEARCH
- A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors
- (2014) Gordana Vlahovic et al. INVESTIGATIONAL NEW DRUGS
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Targeting Microtubules by Natural Agents for Cancer Therapy
- (2014) E. Mukhtar et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
- (2014) L. M. Zasadil et al. Science Translational Medicine
- MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
- (2014) Yubao Wang et al. eLife
- Antimitotic drugs in cancer chemotherapy: Promises and pitfalls
- (2013) Isabel Marzo et al. BIOCHEMICAL PHARMACOLOGY
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- DNA damage associated with mitosis and cytokinesis failure
- (2013) M T Hayashi et al. ONCOGENE
- Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial†
- (2012) M. Reck et al. ANNALS OF ONCOLOGY
- BH3 profiling – Measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions
- (2012) Victoria Del Gaizo Moore et al. CANCER LETTERS
- Abstract 4608: Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression
- (2012) Zong Yuan Gan et al. CANCER RESEARCH
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
- (2012) Thomas J. Lynch et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA breaks and chromosome pulverization from errors in mitosis
- (2012) Karen Crasta et al. NATURE
- The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule Inhibitors
- (2012) James W. Hodge et al. SEMINARS IN ONCOLOGY
- Navitoclax (ABT-263) Accelerates Apoptosis during Drug-Induced Mitotic Arrest by Antagonizing Bcl-xL
- (2011) J. Shi et al. CANCER RESEARCH
- Navitoclax Enhances the Efficacy of Taxanes in Non–Small Cell Lung Cancer Models
- (2011) Nguyen Tan et al. CLINICAL CANCER RESEARCH
- PLK1 as an oncology target: current status and future potential
- (2011) Campbell McInnes et al. DRUG DISCOVERY TODAY
- Drugs that target dynamic microtubules: A new molecular perspective
- (2011) Richard A. Stanton et al. MEDICINAL RESEARCH REVIEWS
- Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction
- (2011) James D. Orth et al. MOLECULAR BIOLOGY OF THE CELL
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- Mitosis is not a key target of microtubule agents in patient tumors
- (2011) Edina Komlodi-Pasztor et al. Nature Reviews Clinical Oncology
- Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
- (2011) T. N. Chonghaile et al. SCIENCE
- Aurora kinase inhibitors as anticancer molecules
- (2010) Hiroshi Katayama et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase
- (2010) Eusebio Manchado et al. CANCER CELL
- Regulation of mRNA Translation during cellular division
- (2010) Gilad Sivan et al. CELL CYCLE
- Caspase-3-mediated degradation of condensin Cap-H regulates mitotic cell death
- (2010) S-K Lai et al. CELL DEATH AND DIFFERENTIATION
- Activity of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Models of Breast Cancer
- (2010) J. W. Purcell et al. CLINICAL CANCER RESEARCH
- Prolonged Prometaphase Blocks Daughter Cell Proliferation Despite Normal Completion of Mitosis
- (2010) Yumi Uetake et al. CURRENT BIOLOGY
- Phosphorylation of Mcl-1 by CDK1–cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest
- (2010) Margaret E Harley et al. EMBO JOURNAL
- Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL
- (2010) Ozgur Kutuk et al. EUROPEAN JOURNAL OF CANCER
- Mcl-1 Stability Determines Mitotic Cell Fate of Human Multiple Myeloma Tumor Cells Treated with the Kinesin Spindle Protein Inhibitor ARRY-520
- (2010) B. J. Tunquist et al. MOLECULAR CANCER THERAPEUTICS
- Stochastic Competition between Mechanistically Independent Slippage and Death Pathways Determines Cell Fate during Mitotic Arrest
- (2010) Hsiao-Chun Huang et al. PLoS One
- An overview of Cdk1-controlled targets and processes
- (2010) Jorrit M Enserink et al. Cell Division
- Evidence that Mitotic Exit Is a Better Cancer Therapeutic Target Than Spindle Assembly
- (2009) Hsiao-Chun Huang et al. CANCER CELL
- Tubulin: A Target for Antineoplastic Drugs into the Cancer Cells but also in the Peripheral Nervous System
- (2009) Annalisa Canta et al. CURRENT MEDICINAL CHEMISTRY
- Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
- (2009) E. A. Perez MOLECULAR CANCER THERAPEUTICS
- Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells
- (2009) P. Kaestner et al. MOLECULAR CANCER THERAPEUTICS
- Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs
- (2008) Karen E. Gascoigne et al. CANCER CELL
- Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
- (2008) J. Shi et al. CANCER RESEARCH
- Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate
- (2008) J. D. Orth et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started